In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of Applied Materials, Inc.
(NASDAQ:AMAT), MRC Global Inc. (NYSE:MRC), Meritor, Inc.
(NYSE:MTOR), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Quaker
Chemical Corporation (NYSE:KWR), and Cubic Corporation (NYSE:CUB),
including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
AMAT DOWNLOAD:
http://Capital-Review.com/register/?so=AMAT MRC DOWNLOAD:
http://Capital-Review.com/register/?so=MRC MTOR DOWNLOAD:
http://Capital-Review.com/register/?so=MTOR CLDX DOWNLOAD:
http://Capital-Review.com/register/?so=CLDX KWR DOWNLOAD:
http://Capital-Review.com/register/?so=KWR CUB DOWNLOAD:
http://Capital-Review.com/register/?so=CUB
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine Applied
Materials, Inc. (NASDAQ:AMAT), MRC Global Inc. (NYSE:MRC), Meritor,
Inc. (NYSE:MTOR), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Quaker
Chemical Corporation (NYSE:KWR), and Cubic Corporation (NYSE:CUB)
on a fundamental level and outlines the overall demand for their
products and services in addition to an in-depth review of the
business strategy, management discussion, and overall direction
going forward. Several excerpts from the recently released reports
are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed February 15th, 2019. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
APPLIED MATERIALS, INC. (AMAT) REPORT
OVERVIEW
Applied Materials' Recent Financial
Performance
For the three months ended October 31st, 2018 vs
October 31st, 2017, Applied Materials reported revenue of
$4,014.00MM vs $3,969.00MM (up 1.13%) and analysts estimated basic
earnings per share $0.86 vs $0.93 (down 7.53%). For the twelve
months ended October 31st, 2018 vs October 31st, 2017, Applied
Materials reported revenue of $17,253.00MM vs $14,537.00MM (up
18.68%) and analysts estimated basic earnings per share $3.27 vs
$3.20 (up 2.19%). Analysts expect earnings to be released on May
16th, 2019. The report will be for the fiscal period ending April
30th, 2019. The reported EPS for the same quarter last year was
$1.22. The estimated EPS forecast for the next fiscal year is $3.94
and is expected to report on November 21st, 2019.
To read the full Applied Materials, Inc. (AMAT) report, download
it here:
http://Capital-Review.com/register/?so=AMAT
-----------------------------------------
MRC GLOBAL INC. (MRC) REPORT OVERVIEW
MRC Global's Recent Financial Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, MRC Global reported revenue of $1,071.00MM
vs $959.00MM (up 11.68%) and analysts estimated basic earnings per
share $0.20 vs -$0.03. For the twelve months ended December 31st,
2017 vs December 31st, 2016, MRC Global reported revenue of
$3,646.00MM vs $3,041.00MM (up 19.89%) and analysts estimated basic
earnings per share $0.28 vs -$1.10. Analysts expect earnings to be
released on May 1st, 2019. The report will be for the fiscal period
ending March 31st, 2019. Reported EPS for the same quarter last
year was $0.13. The estimated EPS forecast for the next fiscal year
is $1.52 and is expected to report on February 13th, 2020.
To read the full MRC Global Inc. (MRC) report, download it here:
http://Capital-Review.com/register/?so=MRC
-----------------------------------------
MERITOR, INC. (MTOR) REPORT OVERVIEW
Meritor's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Meritor reported revenue of $1,038.00MM vs
$903.00MM (up 14.95%) and analysts estimated basic earnings per
share $1.06 vs -$0.41. For the twelve months ended September 30th,
2018 vs September 30th, 2017, Meritor reported revenue of
$4,178.00MM vs $3,347.00MM (up 24.83%) and analysts estimated basic
earnings per share $1.34 vs $3.68 (down 63.59%). Analysts expect
earnings to be released on May 2nd, 2019. The report will be for
the fiscal period ending March 31st, 2019. Reported EPS for the
same quarter last year was $0.75. The estimated EPS forecast for
the next fiscal year is $3.13 and is expected to report on November
13th, 2019.
To read the full Meritor, Inc. (MTOR) report, download it here:
http://Capital-Review.com/register/?so=MTOR
-----------------------------------------
CELLDEX THERAPEUTICS, INC. (CLDX) REPORT
OVERVIEW
Celldex Therapeutics' Recent Financial
Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, Celldex Therapeutics reported revenue of
$0.94MM vs $3.92MM (down 76.02%) and basic earnings per share
-$0.04 vs -$0.20. For the twelve months ended December 31st, 2017
vs December 31st, 2016, Celldex Therapeutics reported revenue of
$12.74MM vs $6.79MM (up 87.78%) and analysts estimated basic
earnings per share -$0.72 vs -$1.27. Analysts expect earnings to be
released on March 6th, 2019. The report will be for the fiscal
period ending December 31st, 2018. The reported EPS for the same
quarter last year was -$2.55. The estimated EPS forecast for the
next fiscal year is -$6.00 and is expected to report on March 6th,
2019.
To read the full Celldex Therapeutics, Inc. (CLDX) report,
download it here:
http://Capital-Review.com/register/?so=CLDX
-----------------------------------------
QUAKER CHEMICAL CORPORATION (KWR) REPORT
OVERVIEW
Quaker Chemical's Recent Financial
Performance
For the three months ended September 30th, 2018
vs September 30th, 2017, Quaker Chemical reported revenue of
$222.02MM vs $212.92MM (up 4.28%) and analysts estimated basic
earnings per share $1.48 vs $0.84 (up 76.19%). For the twelve
months ended December 31st, 2017 vs December 31st, 2016, Quaker
Chemical reported revenue of $820.08MM vs $746.67MM (up 9.83%) and
analysts estimated basic earnings per share $1.53 vs $4.64 (down
67.03%). Analysts expect earnings to be released on February 28th,
2019. The report will be for the fiscal period ending December
31st, 2018. The reported EPS for the same quarter last year was
$1.27. The estimated EPS forecast for the next fiscal year is $7.20
and is expected to report on February 28th, 2019.
To read the full Quaker Chemical Corporation (KWR) report,
download it here:
http://Capital-Review.com/register/?so=KWR
-----------------------------------------
CUBIC CORPORATION (CUB) REPORT OVERVIEW
Cubic's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Cubic reported revenue of $305.26MM vs
$248.39MM (up 22.89%) and analysts estimated basic earnings per
share -$0.23 vs -$0.36. For the twelve months ended September 30th,
2018 vs September 30th, 2017, Cubic reported revenue of $1,202.90MM
vs $1,107.71MM (up 8.59%) and analysts estimated basic earnings per
share $0.45 vs -$0.41. Analysts expect earnings to be released on
May 1st, 2019. The report will be for the fiscal period ending
March 31st, 2019. The reported EPS for the same quarter last year
was -$0.12. The estimated EPS forecast for the next fiscal year is
$2.92 and is expected to report on November 21st, 2019.
To read the full Cubic Corporation (CUB) report, download it
here:
http://Capital-Review.com/register/?so=CUB
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Nicole Garrens, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Applied Materials (NASDAQ:AMAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied Materials (NASDAQ:AMAT)
Historical Stock Chart
From Sep 2023 to Sep 2024